Designing Brain-Computer Interfaces That Connect Neurons to the Digital World
Twenty years after meeting at HMS, two alumni are at the leading edge of efforts to use minimally invasive neural implants to improve human health
biotechnology
COVID-19 long haulers
With the risks of drug development prohibitive, repurposed or repositioned medicines appear the best hope against long-COVID, a condition that still raises many unanswered questions.
The Virome Hunters
Ambitious efforts to catalog viruses across the globe may facilitate our understanding of viral communities and ecology, boost infectious disease diagnostics and surveillance, and spur new therapeutics.
Living in a Microbial World
We live in a microbial world. But can we stay healthier by manipulating the microbes that surround us?
First Deuterated Drug Approved
In April, the US Food and Drug Administration cleared the first deuterated drug, Austedo (deutetrabenazine), from Teva of Petach Tikva, Israel, for the treatment of Huntington’sdisease-related movement disorders.